We first analyzed the frequency of PKA-activating somatic alterations in the TCGA Pan Cancer Atlas (Weinstein et al., 2013), including both PRKACA gain-of-function and PRKAR1A loss-of-function mutations in addition to copy number alterations across multiple cancers (Figure 1A). Here, PRKACA is linked to cancer.